Valerie Odegard
2022
In 2022, Valerie Odegard earned a total compensation of $2.9M as Former President and Chief Scientific Officer at ARS Pharmaceuticals, a 365% increase compared to previous year.
Compensation breakdown
| Option Awards | $801,523 |
|---|---|
| Salary | $336,234 |
| Stock Awards | $222,053 |
| Other | $1,589,592 |
| Total | $2,949,402 |
Odegard received $1.6M in other compensation, accounting for 54% of the total pay in 2022.
Odegard also received $801.5K in option awards, $336.2K in salary and $222.1K in stock awards.
Rankings
In 2022, Valerie Odegard's compensation ranked 1,232nd out of 5,760 executives tracked by ExecPay. In other words, Odegard earned more than 78.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,232 out of 5,760 | 79th |
Division Manufacturing | 596 out of 3,136 | 81st |
Major group Chemicals And Allied Products | 219 out of 1,422 | 85th |
Industry group Drugs | 198 out of 1,323 | 85th |
Industry Pharmaceutical Preparations | 147 out of 969 | 85th |
Source: SEC filing on May 1, 2023.
Odegard's colleagues
We found six more compensation records of executives who worked with Valerie Odegard at ARS Pharmaceuticals in 2022.
2022
Laura Shawver
ARS Pharmaceuticals
Chief Executive Officer
2022
Jonathan Piazza
ARS Pharmaceuticals
Chief Financial Officer
2022
Jeffrey Pepe
ARS Pharmaceuticals
Chief Executive Officer
2022
Richard MSEL
ARS Pharmaceuticals
Chief Executive Officer
2022
Sarina Tanimoto
ARS Pharmaceuticals
Chief Medical Officer
2022
Eric Karas
ARS Pharmaceuticals